Scrip    Clinica    Scrip Regulatory Affairs    Scrip Clinical Research    AnimalPharm   
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Deals
|
M&A
|
Financials
|
Strategy
|
Lifecycle Management
|
Legal
|
BioInvent signs antibody discovery deal with HGS
12 March 2010
Simon Varcoe

simon.varcoe@informa.com

BioInvent and Human Genome Sciences (HGS) have signed a deal to discover, develop and commercialise therapeutic monolconal antibodies that target antigens discovered by HGS.

The deal will initially focus on the development of antibodies for the treatment of inflammation. BioInvent and HGS...



Please Login to read the full article.
 
Not a subscriber? Subscribe to Scrip Request a FREE Trial
JOB OF THE WEEK Promote your vacancy here
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm